News

A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.

Bootstrap Bio...

A newly available kind of genetic testing, called polygenic embryo screening, promises to screen for conditions that can include cancer, obesity, autism, bipolar disorder, even celiac disease. These conditions are informed by many genetic variants and environmental factors - so...

Disclaimer: The views and opinions expressed in this piece are solely my own and do not represent those of my...

"Donald Trump Signs The Pledge" by Michael Vadon 
is licensed under CC BY-SA 2.0.

This is...

a pregnant woman in exam room talks to man in white coat w/ clipboard
By Sarah Kliff and Aatish Bhatia, The New York Times | 01.01.2022

Photo by CDC on Unsplash

After a year of fertility treatments, Yael Geller was thrilled when she found out she...

By Laura Reiley, The Washington Post | 01.01.2022

The goal was to get rid of the patchwork of different labels for foods and ingredients that have been scientifically...

Images of  cells, including sickle cell
By Gina Kolata, The New York Times | 12.28.2021

OpenStax College, CC BY 3.0, via Wikimedia Commons

No doctor ever counseled Lametra Scott and her husband, Rickey Buggs...

By Rafil Kroll-Zaidi, The New York Times Magazine | 12.27.2021

On any given day, CeCe Moore’s inbox is flooded with strangers asking her to solve the mysteries of life and...

By Aniket Aga, Maywa Montenegro de Wit, Scientific American | 12.27.2021

The United Nations Food Systems Summit held last September was eclipsed by a powerful countermobilization effort led by farmers and...

By Amy Klein, The New York Times | 12.18.2021

For patients undergoing in vitro fertilization, there is a common test to help determine the best time to transfer the...

CIRM logo in blue and gray text
By David Jensen, Capitol Weekly | 12.17.2021

One year ago this month, a $5.5 billion wave washed over California’s ambitious stem cell agency and left it refreshed...